Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters

BACKGROUND: The third fatal coronavirus is the novel coronavirus (SARS-CoV-2) that causes novel coronavirus pneumonia (COVID-19) which first broke out in December 2019. Patients will develop rapidly if there is no any intervention, so the risk identification of severe patients is critical. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Changzheng, Deng, Rongrong, Gou, Liyao, Fu, Zhongxiao, Zhang, Xiaomei, Shao, Feng, Wang, Guanzhen, Fu, Weiyang, Xiao, Jianping, Ding, Xiao, Li, Tao, Xiao, Xiulin, Li, Chengbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290538/
https://www.ncbi.nlm.nih.gov/pubmed/32566620
http://dx.doi.org/10.21037/atm-20-3391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290538/
https://www.ncbi.nlm.nih.gov/pubmed/32566620
http://dx.doi.org/10.21037/atm-20-3391

Ejemplares similares